MORGAN STANLEY PLC/CALL/CENTENE/97.5/0.1/20.12.24 Stock

Warrant

DE000ME5BCC8

Real-time Bid/Ask 05:55:29 2024-05-29 am EDT
0.064 EUR / 0.089 EUR -10.47% Intraday chart for MORGAN STANLEY PLC/CALL/CENTENE/97.5/0.1/20.12.24
Current month-8.51%
1 month-21.10%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-29 0.064 -25.58%
24-05-28 0.086 +6.17%
24-05-27 0.081 -19.00%
24-05-24 0.1 -13.04%
24-05-23 0.115 -6.50%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 05:36 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CENTENE CORPORATION
Issuer Morgan Stanley
WKN ME5BCC
ISINDE000ME5BCC8
Date issued 2023-12-14
Strike 97.5 $
Maturity 2024-12-20 (206 Days)
Parity 10 : 1
Emission price 0.35
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.42
Lowest since issue 0.064
Delta0.12x
Omega 10.65
Premium35.23x
Gearing86.58x
Moneyness 0.7458
Difference Strike 24.78 $
Difference Strike %+25.42%
Spread 0.025
Spread %27.78%
Theoretical value 0.0765
Implied Volatility 27.54 %
Total Loss Probability 91.49 %
Intrinsic value 0.000000
Present value 0.0765
Break even 98.33 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
-
More about the company

Ratings for Centene Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Centene Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
72.72 USD
Average target price
89.25 USD
Spread / Average Target
+22.73%
Consensus